Company Accounts and Tax Online 15339739 Board of Directors 1.1.25 31.12.25 31.12.25 No description of principal activity false iso4217:GBP xbrli:pure 15339739 2023-12-09 2024-12-31 15339739 2025-12-31 15339739 2025-01-01 2025-12-31 15339739 2024-12-31 15339739 countries:EnglandWales 2025-01-01 2025-12-31 15339739 curr:PoundSterling 2025-01-01 2025-12-31 15339739 uk-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 15339739 uk-bus:Micro-entities 2025-01-01 2025-12-31 15339739 uk-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 15339739 uk-bus:FullAccounts 2025-01-01 2025-12-31 15339739 uk-bus:RegisteredOffice 2025-01-01 2025-12-31 15339739 uk-bus:Director1 2025-01-01 2025-12-31 15339739 uk-bus:Director1 2025-01-01 15339739 uk-bus:Director1 2025-12-31 15339739 core:AfterOneYear 2025-12-31 15339739 core:AfterOneYear 2024-12-31 15339739 core:WithinOneYear 2025-12-31 15339739 core:WithinOneYear 2024-12-31 15339739 core:WithinOneYear 2025-01-01 2025-12-31 15339739 core:AfterOneYear 2025-12-31 15339739 core:AfterOneYear 2024-12-31 15339739 core:AfterOneYear 2025-01-01 2025-12-31 15339739 core:ShareCapital 2025-12-31 15339739 core:ShareCapital 2024-12-31 15339739 core:RevaluationReserve 2025-12-31 15339739 core:RevaluationReserve 2024-12-31 15339739 core:RetainedEarningsAccumulatedLosses 2025-12-31 15339739 core:RetainedEarningsAccumulatedLosses 2024-12-31 15339739 1 2025-01-01 2025-12-31

# KIRRAN PHARM LTD

## Company Registration Number:
15339739 (England and Wales)

## Unaudited micro entity accounts for the year ended 31 December 2025

## Period of accounts

## Start date: 01 January 2025

## End date: 31 December 2025

# KIRRAN PHARM LTD

## Contents of the Financial Statements

for the Period Ended 31 December 2025

Company Information - 3 |
Balance sheet - 4 |
Footnotes to the Balance Sheet - 6 |

# KIRRAN PHARM LTD

## Company Information

for the Period Ended 31 December 2025

Registered office: |  | 41 Bellott Street Manchester England M8 0PQ
Company Registration Number: |  | 15339739 (England and Wales)

# KIRRAN PHARM LTD

## Balance sheet

As at 31 December 2025

| 2025 £ | 13 months to 31 Dec 2024 £
--- | --- | ---
Called up share capital not paid: | 0 | 0
Fixed Assets: | 0 | 0
Current assets: | 7,164 | 2,881
Creditors: amounts falling due within one year: | ( 6,578 ) | ( 2,648 )
Net current assets (liabilities): | 586 | 233
Total assets less current liabilities: | 586 | 233
Provision for liabilities: | ( 585 ) | ( 232 )
Total net assets (liabilities): | 1 | 1
Capital and reserves: | 1 | 1

# KIRRAN PHARM LTD

## Balance sheet continued

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 8 January 2026
And Signed On Behalf Of The Board By:

Name: Kirran Zahra QAISAR
Status: Director

The notes form part of these financial statements

# KIRRAN PHARM LTD

## Footnotes to the Financial Statements

for the Period Ended 31 December 2025

- ## 1. Employee Information

  Average number of employees: 1

# KIRRAN PHARM LTD

## Footnotes to the Financial Statements

for the Period Ended 31 December 2025

- ## 2. Off balance sheet disclosure

  No